Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polyglandular autoimmune syndromes].

E Otto Buczkowska, P Jarosz Chobot

    Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego : Organ Polskiego Towarzystwa Endokrynologow Dzieciecych
    |June 24, 2003
    PubMed
    Summary

    Polyglandular autoimmune diseases involve multiple organ-specific autoimmune disorders. Approximately 25% of patients with one autoimmune condition may develop others throughout their lifetime.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Glucose homeostasis. II. Homeostasis disturbances--hypoglycemia in newborns and infants].

    Przeglad lekarski·2001
    Same author

    [Glucose homeostasis in children. I. Regulation of blood glucose].

    Przeglad lekarski·2001
    Same author

    [STUDIES ON THE EFFECT OF LOW-FREQUENCY MECHANICAL VIBRATIONS ON BLOOD CHANGES IN WHITE RATS. II. BEHAVIOR OF BLOOD SERUM PROTEINS].

    Acta physiologica Polonica·1964
    See all related articles

    Area of Science:

    • Endocrinology
    • Immunology
    • Genetics

    Context:

    • Polyglandular autoimmune diseases (PAGD) represent a group of rare disorders.
    • Characterized by the simultaneous or sequential occurrence of autoimmune conditions affecting multiple endocrine glands.
    • PAGD are classified into types I, II, and III, each with distinct clinical and genetic features.

    Purpose:

    • To review the current understanding of the pathophysiology, clinical manifestations, and genetic basis of polyglandular autoimmune diseases.
    • To highlight the diagnostic challenges and management strategies for these complex conditions.
    • To emphasize the importance of early diagnosis and comprehensive screening for associated autoimmune disorders.

    Summary:

    • PAGD are defined by the presence of two or more organ-specific autoimmune disorders.
    • Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) or type I PAGD is caused by mutations in the AIRE gene.
    • Type II PAGD (Schmidt syndrome) is associated with HLA-DR3 and HLA-DR4 haplotypes and involves autoimmune thyroid disease and type 1 diabetes.
    • Type III PAGD is characterized by autoimmune thyroid disease and other autoimmune conditions, excluding type 1 diabetes and Addison's disease.

    Impact:

    • Understanding the genetic and immunological underpinnings of PAGD is crucial for developing targeted therapies.
    • Improved diagnostic criteria and screening protocols can lead to earlier detection and better management of PAGD.
    • Raising awareness among healthcare professionals about the potential for multiple autoimmune conditions in affected individuals can improve patient outcomes.

    Related Experiment Videos